Suppr超能文献

美国育龄非孕妇和孕妇中处方药使用情况:1999 - 2006年美国国家健康与营养检查调查(NHANES)

Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006.

作者信息

Tinker Sarah C, Broussard Cheryl S, Frey Meghan T, Gilboa Suzanne M

机构信息

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Mail Stop E-86, 1600 Clifton Road, Atlanta, GA, 30333, USA,

出版信息

Matern Child Health J. 2015 May;19(5):1097-106. doi: 10.1007/s10995-014-1611-z.

Abstract

Many prescription medications have limited information regarding safety for use during pregnancy. In order to inform research on safer medication use during pregnancy, we examined prescription medication use among women in the United States. We analyzed data from the 1999-2006 National Health and Nutrition Examination Survey (NHANES) to estimate the prevalence of prescription medication use in the past 30 days among pregnant women and non-pregnant women of childbearing age (15-44 years) and to ascertain the most commonly reported prescription medications by women in these groups. We assessed how the most commonly reported medications differed among groups defined by selected demographic characteristics, including age, race/ethnicity, and markers of socioeconomic status. Prescription medication use in the past 30 days was reported by 22 % of pregnant women and 47 % of non-pregnant women of childbearing age. The most commonly reported prescription medications by NHANES participants differed somewhat by pregnancy status; allergy and anti-infective medications were more common among pregnant women, while oral contraceptives were more common among non-pregnant women. Use of prescription medication for asthma and thyroid disorders was reported by both groups. Although prescription medication use in the previous 30 days was less common among pregnant women than non-pregnant women, its use was reported among almost 1 in 4 pregnant women. Many of the most common medications reported were for the treatment of chronic medical conditions. Given the potential impact of medications on the developing fetus, our data underscore the importance of understanding the safety of these medications during pregnancy.

摘要

许多处方药关于孕期使用安全性的信息有限。为了为孕期更安全用药的研究提供信息,我们调查了美国女性的处方药使用情况。我们分析了1999 - 2006年国家健康和营养检查调查(NHANES)的数据,以估计孕妇和育龄非孕妇(15 - 44岁)在过去30天内使用处方药的患病率,并确定这些群体中女性最常报告使用的处方药。我们评估了按选定人口统计学特征(包括年龄、种族/族裔和社会经济地位指标)定义的群体中最常报告的药物有何不同。22%的孕妇和47%的育龄非孕妇报告在过去30天内使用过处方药。NHANES参与者最常报告的处方药因怀孕状况而有所不同;过敏和抗感染药物在孕妇中更常见,而口服避孕药在非孕妇中更常见。两组都报告了用于哮喘和甲状腺疾病的处方药使用情况。尽管孕妇在过去30天内使用处方药的情况比非孕妇少,但几乎四分之一的孕妇报告使用过。报告的许多最常见药物用于治疗慢性疾病。鉴于药物对发育中胎儿的潜在影响,我们的数据强调了了解这些药物在孕期安全性的重要性。

相似文献

2
Trends in Prescription Medication Use Among Children and Adolescents-United States, 1999-2014.
JAMA. 2018 May 15;319(19):2009-2020. doi: 10.1001/jama.2018.5690.
3
Prevalence of alcohol-interactive prescription medication use among current drinkers: United States, 1999 to 2010.
Alcohol Clin Exp Res. 2015 Feb;39(2):371-9. doi: 10.1111/acer.12633. Epub 2015 Jan 16.
4
The Most Commonly Dispensed Prescription Medications Among Pregnant Women Enrolled in the U.S. Medicaid Program.
Obstet Gynecol. 2015 Sep;126(3):465-473. doi: 10.1097/AOG.0000000000000982.
5
Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence.
Am J Obstet Gynecol. 2024 Aug;231(2):250.e1-250.e16. doi: 10.1016/j.ajog.2023.12.020. Epub 2023 Dec 19.
10
Prevalence, trends, and characteristics of polypharmacy among US pregnant women aged 15 to 44 years: NHANES 1999 to 2016.
Medicine (Baltimore). 2023 Jun 2;102(22):e33828. doi: 10.1097/MD.0000000000033828.

引用本文的文献

1
Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence.
Am J Obstet Gynecol. 2024 Aug;231(2):250.e1-250.e16. doi: 10.1016/j.ajog.2023.12.020. Epub 2023 Dec 19.
2
Asthma and pregnancy.
Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S123. doi: 10.1590/1806-9282.2023S123. eCollection 2023.
3
Prevalence, trends, and characteristics of polypharmacy among US pregnant women aged 15 to 44 years: NHANES 1999 to 2016.
Medicine (Baltimore). 2023 Jun 2;102(22):e33828. doi: 10.1097/MD.0000000000033828.
4
The Association of Periconception Asthma Medication Discontinuation with Adverse Obstetric Outcomes.
Am J Perinatol. 2024 May;41(S 01):e2089-e2097. doi: 10.1055/a-2097-1468. Epub 2023 May 22.
5
Prevalence of polypharmacy in pregnancy: a systematic review.
BMJ Open. 2023 Mar 6;13(3):e067585. doi: 10.1136/bmjopen-2022-067585.
7
Drug purchases prior to conception and the risk of gestational diabetes mellitus.
J Int Med Res. 2022 Nov;50(11):3000605221138455. doi: 10.1177/03000605221138455.
8
Challenges in the successful management of asthma during conception, pregnancy and delivery.
Breathe (Sheff). 2022 Jun;18(2):220013. doi: 10.1183/20734735.0013-2022. Epub 2022 Aug 9.
9
Sociodemographic variation in prescriptions dispensed in early pregnancy in Northern Ireland 2010-2016.
PLoS One. 2022 Aug 22;17(8):e0267710. doi: 10.1371/journal.pone.0267710. eCollection 2022.
10
Sterol Biosynthesis Inhibition in Pregnant Women Taking Prescription Medications.
ACS Pharmacol Transl Sci. 2021 Feb 17;4(2):848-857. doi: 10.1021/acsptsci.1c00012. eCollection 2021 Apr 9.

本文引用的文献

1
2
Increase in prescription opioid use during pregnancy among Medicaid-enrolled women.
Obstet Gynecol. 2014 May;123(5):997-1002. doi: 10.1097/AOG.0000000000000208.
3
Shifts in intended and unintended pregnancies in the United States, 2001-2008.
Am J Public Health. 2014 Feb;104 Suppl 1(Suppl 1):S43-8. doi: 10.2105/AJPH.2013.301416. Epub 2013 Dec 19.
4
Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk.
Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):1013-8. doi: 10.1002/pds.3495. Epub 2013 Jul 29.
7
Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort.
J Clin Endocrinol Metab. 2013 Jul;98(7):2725-33. doi: 10.1210/jc.2012-4233. Epub 2013 Jun 6.
8
Neonatal outcomes and birth weight in pregnancies complicated by maternal thyroid disease.
Am J Epidemiol. 2013 Sep 1;178(5):731-40. doi: 10.1093/aje/kwt031. Epub 2013 May 10.
10
Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes.
Eur Respir J. 2013 May;41(5):1082-90. doi: 10.1183/09031936.00195111. Epub 2012 Aug 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验